Table 1 Patient and Tumor Characteristics by Vitamin D level
Vitamin D level | p | ||
|---|---|---|---|
< 20 ng/ml | ≥ 20 ng/ml | ||
Population | 42% (136) | 58% (191) | |
Median age | 49.5 | 50 | 0.1 |
Histological type | 0.3 | ||
Ductal carcinoma | 83.9% (99) | 85.9% (122) | |
Lobular carcinoma | 7.6 (9) | 9.9% (14) | |
Other | 8.5% (10) | 4.2% (6) | |
NA | (18) | (49) | |
Tumor subtypes | 0.02 | ||
HER2+ | 20.6% (28) | 34.2% (65) | |
HR+/HER2- | 47.1% (64) | 41.6% (79) | |
TNBC | 32.4% (44) | 24.2% (46) | |
NA | 0 | 1 | |
Tumor size | 0.7 | ||
T1 | 12.5% (17) | 9.4% (17) | |
T2 | 56.6% (77) | 62.6%(119) | |
T3 | 19.1% (26) | 19.5% (37) | |
T4 | 11.8% (16) | 8.9% (17) | |
NA | 0 | 1 | |
Nodal status | 0.4 | ||
N0 | 43.7% (59) | 19.5% (93) | |
N1 | 46.7% (63) | 43.6% (82) | |
N2 | 8.9% (12) | 5.3% (10) | |
N3 | 0.7% (1) | 1.6% (3) | |
NA | 1 | 3 | |
SBR grade | 0.8 | ||
II | 46.6% (62) | 45.5% (85) | |
III | 53.4% (71) | 54.5%(102) | |
NA | 3 | 4 | |
Clinical stage | 0.96 | ||
I-II | 72.8% (99) | 73% (138) | |
III | 27.2% (37) | 27% (51) | |
NA | 0 | 2 | |